Pulmonary Embolism News and Research

RSS
A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung.
HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range

HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range

Study reveals increase in adverse outcomes for people taking aspirin and warfarin

Study reveals increase in adverse outcomes for people taking aspirin and warfarin

New collaboration aims to prevent life-threatening adverse reactions to medications

New collaboration aims to prevent life-threatening adverse reactions to medications

New PET/CT tracer shows high detection rate for diagnosis of acute venous thromboembolism

New PET/CT tracer shows high detection rate for diagnosis of acute venous thromboembolism

Scientists show treatment success in minimally invasive heart valve procedure

Scientists show treatment success in minimally invasive heart valve procedure

New study adds evidence to efficacy and safety of low-dose vaginal estrogen

New study adds evidence to efficacy and safety of low-dose vaginal estrogen

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

New clinical practice guidelines for managing venous thromboembolism released

New clinical practice guidelines for managing venous thromboembolism released

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

New standard of care aims to prevent deaths caused by largely preventable blood clots

New standard of care aims to prevent deaths caused by largely preventable blood clots

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Using clinical quality registers to compare institutions or physicians may be misleading

Using clinical quality registers to compare institutions or physicians may be misleading

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots